Teleflex Incorporated (TFX)

USD 172.66

(-3.15%)

EBITDA Summary of Teleflex Incorporated

  • Teleflex Incorporated's latest annual EBITDA in 2023 was 792.26 Million USD , up 9.74% from previous year.
  • Teleflex Incorporated's latest quarterly EBITDA in 2024 Q3 was 110.91 Million USD , up 17.47% from previous quarter.
  • Teleflex Incorporated reported an annual EBITDA of 751.65 Million USD in 2022, down -6.56% from previous year.
  • Teleflex Incorporated reported an annual EBITDA of 873.09 Million USD in 2021, up 15.57% from previous year.
  • Teleflex Incorporated reported a quarterly EBITDA of 110.91 Million USD for 2024 Q3, up 17.47% from previous quarter.
  • Teleflex Incorporated reported a quarterly EBITDA of 194.26 Million USD for 2024 Q2, up 204.24% from previous quarter.

Annual EBITDA Chart of Teleflex Incorporated (2023 - 1989)

Historical Annual EBITDA of Teleflex Incorporated (2023 - 1989)

Year EBITDA EBITDA Growth
2023 792.26 Million USD 9.74%
2022 751.65 Million USD -6.56%
2021 873.09 Million USD 15.57%
2020 665.97 Million USD 4.67%
2019 634.23 Million USD 7.98%
2018 532.62 Million USD 12.4%
2017 522.72 Million USD 10.23%
2016 418.57 Million USD 13.99%
2015 414.36 Million USD 4.26%
2014 396.7 Million USD 13.48%
2013 325.61 Million USD 14.34%
2012 -26.39 Million USD 32.28%
2011 288.86 Million USD -34.64%
2010 302.71 Million USD -6.49%
2009 353.78 Million USD -12.93%
2008 453.84 Million USD 20.95%
2007 313.86 Million USD -7.33%
2006 309.2 Million USD 4.13%
2005 284.13 Million USD 0.58%
2004 308.41 Million USD -82.47%
2003 302.79 Million USD 657.1%
2002 307.27 Million USD 3.85%
2001 280.56 Million USD 9.42%
2000 256.41 Million USD 12.51%
1999 227.9 Million USD 12.88%
1998 201.9 Million USD 19.68%
1997 168.7 Million USD 20.93%
1996 139.5 Million USD 7.31%
1995 130 Million USD 13.64%
1994 114.4 Million USD 20.68%
1993 94.8 Million USD 19.55%
1992 82.5 Million USD 12.48%
1991 74 Million USD 6.63%
1990 69.4 Million USD 27.34%
1989 54.5 Million USD 1.68%

Peer EBITDA Comparison of Teleflex Incorporated

Name EBITDA EBITDA Difference
Alcon Inc. 2.39 Billion USD 66.893%
AptarGroup, Inc. 663.83 Million USD -19.346%
Baxter International Inc. 2.77 Billion USD 71.46%
Becton, Dickinson and Company 2.42 Billion USD 67.329%
Bausch + Lomb Corporation 586 Million USD -35.198%
Haemonetics Corporation 262.09 Million USD -202.276%
Envista Holdings Corp 171.1 Million USD -363.039%
ResMed Inc. 1.6 Billion USD 50.494%
Warby Parker Inc. -30.21 Million USD 2722.335%
West Pharmaceutical Services, Inc. 847.8 Million USD 6.551%